Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach
Abstract Using successful genome-wide association results in psychiatry for drug repurposing is an ongoing challenge. Databases collecting drug targets and gene annotations are growing and can be harnessed to shed a new light on psychiatric disorders. We used genome-wide association study (GWAS) sum...
Guardado en:
Autores principales: | H. A. Gaspar, G. Breen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4fb5cf2ef0a5453dba3fd3a890202636 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci
por: Atsushi Takata, et al.
Publicado: (2017) -
Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia
por: V. Bansal, et al.
Publicado: (2018) -
Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet
por: Hua Yu, et al.
Publicado: (2021) -
Genome wide association for addiction: replicated results and comparisons of two analytic approaches.
por: Tomas Drgon, et al.
Publicado: (2010) -
Targeted genome-wide enrichment of functional regions.
por: Periannan Senapathy, et al.
Publicado: (2010)